NCT07577076

Brief Summary

The purpose of this study is to investigate whether a diaphragmatic breathing exercise using the air stacking technique can improve respiratory function and trunk control in patients with stroke. The experimental group will perform an air stacking-based diaphragmatic breathing exercise using an Ambu-bag, combined with neurodevelopmental treatment, three times per week for 20 minutes over a 4-week period. The control group will receive therapist-guided diaphragmatic breathing exercises with the same frequency and duration, together with the same neurodevelopmental treatment. All participants will be assessed before and after the intervention for pulmonary function, chest wall expansion, and trunk control ability, as well as the Korean version of the Trunk Impairment Scale (K-TIS), the Five Times Sit-to-Stand Test (FTSTS), and the Borg Rating of Perceived Exertion (Borg RPE). Changes between the two groups will be compared to determine the therapeutic effectiveness of the air stacking technique.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 25, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 21, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 21, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 28, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 11, 2026

Completed
Last Updated

May 11, 2026

Status Verified

May 1, 2026

Enrollment Period

5 months

First QC Date

April 28, 2026

Last Update Submit

May 5, 2026

Conditions

Keywords

StrokeHemiplegiaRespiratory rehabilitationDiaphragmatic breathingAir stackingAmbu-bagPulmonary functionTrunk Impairment Scale

Outcome Measures

Primary Outcomes (4)

  • Change in Forced Vital Capacity (FVC)

    Forced vital capacity (FVC) will be assessed using spirometry at baseline and 4 weeks after the start of the intervention. The outcome measure is the change in FVC from baseline to 4 weeks in each group.

    Baseline and 4 weeks after the start of intervention

  • Change in Forced Expiratory Volume in 1 Second (FEV1)

    Forced expiratory volume in 1 second (FEV1) will be assessed using spirometry at baseline and 4 weeks after the start of the intervention. The outcome measure is the change in FEV1 from baseline to 4 weeks in each group.

    Baseline and 4 weeks after the start of intervention

  • Change in FEV1/FVC ratio

    The ratio of forced expiratory volume in 1 second to forced vital capacity (FEV1/FVC) will be assessed using spirometry at baseline and 4 weeks after the start of the intervention. The outcome measure is the change in FEV1/FVC from baseline to 4 weeks in each group.

    Baseline and 4 weeks after the start of intervention

  • Change in Peak Expiratory Flow (PEF)

    Peak expiratory flow (PEF) will be assessed using spirometry at baseline and 4 weeks after the start of the intervention. The outcome measure is the change in PEF from baseline to 4 weeks in each group.

    Baseline and 4 weeks after the start of intervention

Secondary Outcomes (3)

  • Change in Trunk Function (Korean Version of the Trunk Impairment Scale, K-TIS)

    Baseline and 4 weeks after the start of intervention

  • Change in Functional Lower Extremity Performance (Five Times Sit-to-Stand Test, FTSTS)

    Baseline and 4 weeks after the start of intervention

  • Change in Perceived Exertion (Borg Rating of Perceived Exertion Scale)

    Baseline and 4 weeks after the start of intervention

Study Arms (2)

Air stacking-assisted diaphragmatic breathing

EXPERIMENTAL

articipants in this arm will receive diaphragmatic breathing exercises using the air stacking technique with an Ambu-bag three times per week for 20 minutes over 4 weeks, in addition to routine neurodevelopmental treatment.

Behavioral: Air stacking-assisted diaphragmatic breathing

diaphragmatic breathing

ACTIVE COMPARATOR

Participants in this arm will receive diaphragmatic breathing exercises three times per week for 20 minutes over 4 weeks, together with the same neurodevelopmental treatment as the experimental group.

Behavioral: diaphragmatic breathing

Interventions

diaphragmatic breathing exercise performed three times per week for 20 minutes over 4 weeks, together with the same neurodevelopmental treatment as the experimental group.

diaphragmatic breathing

Diaphragmatic breathing exercise using the air stacking technique with an Ambu-bag, performed three times per week for 20 minutes over 4 weeks, in addition to routine neurodevelopmental treatment.

Air stacking-assisted diaphragmatic breathing

Eligibility Criteria

Age19 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Inpatients diagnosed with stroke (intracerebral hemorrhage or cerebral infarction) at a general hospital in Daegu, currently receiving physical therapy
  • Onset of stroke at least 3 months prior to enrollment
  • Spasticity grade of 2 or less on the Modified Ashworth Scale
  • No congenital deformity or fracture of the thorax or other orthopedic conditions affecting the chest wall
  • No history of pulmonary disease before or after the stroke
  • Able to perform respiratory exercises as instructed
  • Mini-Mental State Examination-Korean version (MMSE-K) score of 24 or higher, indicating sufficient cognitive ability to understand the study procedures
  • Presence of decreased pulmonary function (reduced pulmonary function test parameters) at baseline

You may not qualify if:

  • Acute stroke status or onset of stroke less than 3 months prior to enrollment
  • Severe cardiovascular or respiratory disease that makes participation in respiratory exercise unsafe or impossible
  • Cognitive impairment or communication disorder that prevents understanding or performing the study procedures
  • Any other medical or safety condition judged by the investigator to make participation in the study inappropriate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Daegu Fatima Hospital

Daegu, Daegu, 41199, South Korea

Location

MeSH Terms

Conditions

StrokeHemiplegia

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessments will be performed by a physical therapist who is blinded to group allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Physical Therapist, Principal Investigator

Study Record Dates

First Submitted

April 28, 2026

First Posted

May 11, 2026

Study Start

September 25, 2025

Primary Completion

February 21, 2026

Study Completion

February 21, 2026

Last Updated

May 11, 2026

Record last verified: 2026-05

Locations